A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer

Clinical trial NCT07768436 · RECRUITING

Trial details

NCT number: NCT07768436
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Breast Breast Cancer Triple Negative Breast Cancer

Start date: 2026-08-11
Primary completion: 2030-08-11
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.